Stories From the Marketplace, a look back at the New Zealand Capital Markets
KPMG: IFRS 17 Webcast Series

New evidence that the HPV vaccine may be as important for males as females

Matthew Herper at Statnews has this fascinating article on the importance of HPV vaccination. In New Zealand HPV vaccination was originally only funded for females between, but this was extended to males in 2017. The prevention of cancers of the mouth and throat through the use of this vaccine will save lives and treatment costs, enhancing health and wellbeing for all. 

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.